Disclaimer:

Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.

Calcipotriene and Betamethasone Dipropionate

×

Overview

What is Calcipotriene and Betamethasone Dipropionate?

Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% contains calcipotriene hydrate and betamethasone dipropionate. It is intended for topical use only.

Calcipotriene hydrate is a synthetic vitamin D analogue.

Chemically, calcipotriene hydrate is (5Z,7E,22E,24S)-24-cyclopropyl-9,10-secochola-5,7,10(19),22-tetraene-1(alpha),3(beta),24-triol,hydrate, with the empirical formula CHOHO, a molecular weight of 430.6, and the following structural formula:

Betamethasone dipropionate is a synthetic corticosteroid.

Betamethasone dipropionate has the chemical name 9-fluoro-11(beta),17,21-trihydroxy-16(beta)-methylpregna-1,4-diene-3,20-dione17,21-dipropionate, with the empirical formula CHFO, a molecular weight of 504.6, and the following structural formula:

Betamethasone dipropionate is a white to almost white odorless powder.



What does Calcipotriene and Betamethasone Dipropionate look like?



What are the available doses of Calcipotriene and Betamethasone Dipropionate?

Ointment, 0.005%/0.064%

What should I talk to my health care provider before I take Calcipotriene and Betamethasone Dipropionate?

How should I use Calcipotriene and Betamethasone Dipropionate?

Apply an adequate layer of Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% Ointment to the affected area(s) once daily for up to 4 weeks. Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% Ointment should be rubbed in gently and completely. Patients should wash their hands after applying Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% Ointment. Therapy should be discontinued when control is achieved.

Patients 18 years and older should not use more than 100 g per week and patients 12 to 17 years should not use more than 60 g per week. Treatment of more than 30% body surface area is not recommended.

Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% Ointment should not be used with occlusive dressings unless directed by a physician. Avoid use on the face, groin, or axillae, or if skin atrophy is present at the treatment site.

Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% Ointment is not for oral, ophthalmic, or intravaginal use.


What interacts with Calcipotriene and Betamethasone Dipropionate?

Sorry No Records found


What are the warnings of Calcipotriene and Betamethasone Dipropionate?

Sorry No Records found


What are the precautions of Calcipotriene and Betamethasone Dipropionate?

Sorry No Records found


What are the side effects of Calcipotriene and Betamethasone Dipropionate?

Sorry No records found


What should I look out for while using Calcipotriene and Betamethasone Dipropionate?

None.


What might happen if I take too much Calcipotriene and Betamethasone Dipropionate?

Topically applied Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% Ointment can be absorbed in sufficient amounts to produce systemic effects .


How should I store and handle Calcipotriene and Betamethasone Dipropionate?

Procedures for proper handling and disposal of anticancer drugs should be considered. Several guidelines on this subject have been published [].


×

Clinical Information

Chemical Structure

No Image found
Clinical Pharmacology

3

Non-Clinical Toxicology
None.

(Clinical Evaluation of Drug Interactions Conducted with Metformin Hydrochloride Tablets)

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.

×

Reference

This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"

While we update our database periodically, we cannot guarantee it is always updated to the latest version.

×

Review

Rate this treatment and share your opinion


Learn about User Reviews

Helpful tips to write a good review:

  1. Only share your first hand experience as a consumer or a care giver.
  2. Describe your experience in the Comments area including the benefits, side effects and how it has worked for you. Do not provide personal information like email addresses or telephone numbers.
  3. Fill in the optional information to help other users benefit from your review.

Reason for Taking This Treatment

(required)

Click the stars to rate this treatment

Effectiveness (required)

This medication has worked for me.




Ease of Use (required)

This medication has been easy for me to use.




Satisfaction (required)

Overall, I have been satisfied with my experience.




Write a brief description of your experience with this treatment:

2000 characters remaining

Optional Information

Help others benefit from your review by filling in the information below.
I am a:
Gender:
×

Professional

Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72
×

Tips

Tips

×

Interactions

Interactions

A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).